|
|
|
|
Vol. 62, Issue 4, 788-794, October 2002
Departments of Biochemistry (S.V., S.R., T.A., P.H.M.) and
Chemistry (J.T.A.S., M.P.), University of Kuopio, Kuopio, Finland
The crystal structures of the ligand binding domain of human vitamin D
receptor (VDR) complexed with its natural ligand or the superagonists
MC1288 or KH1060 have recently been reported. The crystallized ligand
binding domain (LBD) of VDR, however, differs from the full-length VDR
with respect to deletion of 50 amino acids between its helices 2 and 3. In this study, we investigated structurally and functionally important
amino acid interactions within the ligand binding pocket of the
full-length VDR in the presence of several synthetic vitamin
D3 analogs. We used site-directed mutagenesis scanning
combined with limited proteolytic digestion, electrophoretic mobility
shift assay, and reporter gene assay and correlated the findings with
the crystal structures of truncated VDR LBD. Our results suggest that
structurally different agonists have distinct ligand-receptor
interactions and that the amino acid residues H229, D232, E269, F279,
and Y295 are critical for the agonistic conformation of the VDR. Our
biological data, which were obtained with the full-length VDR, fit well
with the crystal structure of the truncated VDR LBD and suggest that
removal of the insertion domain between helices 2 and 3 of the receptor
does not markedly influence the functionality of the VDR.
This article has been cited by other articles:
![]() |
F. Molnar, M. Perakyla, and C. Carlberg Vitamin D Receptor Agonists Specifically Modulate the Volume of the Ligand-binding Pocket J. Biol. Chem., April 14, 2006; 281(15): 10516 - 10526. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Perakyla, M. Malinen, K.-H. Herzig, and C. Carlberg Gene Regulatory Potential of Nonsteroidal Vitamin D Receptor Ligands Mol. Endocrinol., August 1, 2005; 19(8): 2060 - 2073. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gonzalez, P. Samenfeld, M. Perakyla, and C. Carlberg Corepressor Excess Shifts the Two-Side Chain Vitamin D Analog Gemini from an Agonist to an Inverse Agonist of the Vitamin D Receptor Mol. Endocrinol., October 1, 2003; 17(10): 2028 - 2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vaisanen, M. Perakyla, J. I. Karkkainen, M. R. Uskokovic, and C. Carlberg Structural Evaluation of the Agonistic Action of a Vitamin D Analog with Two Side Chains Binding to the Nuclear Vitamin D Receptor Mol. Pharmacol., June 1, 2003; 63(6): 1230 - 1237. [Abstract] [Full Text] [PDF] |
||||